CASI Pharmaceuticals Inc (NASDAQ:CASI)

6.23
BATS BZX Real-Time Price
As of 12:21pm ET
 +0.53 / +9.30%
Today’s Change
0.92
Today|||52-Week Range
8.42
+91.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$676.6M

Company Description

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The firm develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO. The company was founded in 1991 and is headquartered in Rockville, MD.

Contact Information

CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Rockville Maryland 20850
P:(240) 864-2600
Investor Relations:

Employees

Shareholders

Individual stakeholders40.21%
Other institutional3.72%
Mutual fund holders2.45%

Top Executives

Ken Keyong RenChief Executive Officer & Director
Cynthia Wong HuCOO, Secretary, Vice President & General Counsel
Sara B. CapitelliChief Accounting Officer & Vice President-Finance
Alexander A. ZukiwskiChief Medical Officer
James E. GoldschmidtVice President-Business Development